chr2-210648491-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001875.5(CPS1):​c.3355G>A​(p.Ala1119Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00248 in 1,613,204 control chromosomes in the GnomAD database, including 93 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A1119V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.013 ( 51 hom., cov: 33)
Exomes 𝑓: 0.0013 ( 42 hom. )

Consequence

CPS1
NM_001875.5 missense

Scores

2
9
6

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 6.08

Publications

5 publications found
Variant links:
Genes affected
CPS1 (HGNC:2323): (carbamoyl-phosphate synthase 1) The mitochondrial enzyme encoded by this gene catalyzes synthesis of carbamoyl phosphate from ammonia and bicarbonate. This reaction is the first committed step of the urea cycle, which is important in the removal of excess urea from cells. The encoded protein may also represent a core mitochondrial nucleoid protein. Three transcript variants encoding different isoforms have been found for this gene. The shortest isoform may not be localized to the mitochondrion. Mutations in this gene have been associated with carbamoyl phosphate synthetase deficiency, susceptibility to persistent pulmonary hypertension, and susceptibility to venoocclusive disease after bone marrow transplantation.[provided by RefSeq, May 2010]
CPS1 Gene-Disease associations (from GenCC):
  • carbamoyl phosphate synthetase I deficiency disease
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Myriad Women’s Health, Orphanet, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0064868033).
BP6
Variant 2-210648491-G-A is Benign according to our data. Variant chr2-210648491-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 235274.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0134 (2042/152282) while in subpopulation AFR AF = 0.0464 (1926/41552). AF 95% confidence interval is 0.0446. There are 51 homozygotes in GnomAd4. There are 959 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 51 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001875.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CPS1
NM_001875.5
MANE Select
c.3355G>Ap.Ala1119Thr
missense
Exon 27 of 38NP_001866.2
CPS1
NM_001369256.1
c.3388G>Ap.Ala1130Thr
missense
Exon 28 of 39NP_001356185.1
CPS1
NM_001122633.3
c.3355G>Ap.Ala1119Thr
missense
Exon 28 of 39NP_001116105.2P31327-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CPS1
ENST00000233072.10
TSL:1 MANE Select
c.3355G>Ap.Ala1119Thr
missense
Exon 27 of 38ENSP00000233072.5P31327-1
CPS1
ENST00000430249.7
TSL:1
c.3373G>Ap.Ala1125Thr
missense
Exon 28 of 39ENSP00000402608.2P31327-3
CPS1
ENST00000451903.3
TSL:1
c.2002G>Ap.Ala668Thr
missense
Exon 17 of 28ENSP00000406136.2P31327-2

Frequencies

GnomAD3 genomes
AF:
0.0134
AC:
2040
AN:
152164
Hom.:
51
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0464
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00576
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.0115
GnomAD2 exomes
AF:
0.00337
AC:
847
AN:
251162
AF XY:
0.00250
show subpopulations
Gnomad AFR exome
AF:
0.0475
Gnomad AMR exome
AF:
0.00162
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000114
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.00135
AC:
1965
AN:
1460922
Hom.:
42
Cov.:
30
AF XY:
0.00121
AC XY:
878
AN XY:
726848
show subpopulations
African (AFR)
AF:
0.0488
AC:
1629
AN:
33412
American (AMR)
AF:
0.00244
AC:
109
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26110
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39668
South Asian (SAS)
AF:
0.0000464
AC:
4
AN:
86236
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53236
Middle Eastern (MID)
AF:
0.00139
AC:
8
AN:
5762
European-Non Finnish (NFE)
AF:
0.0000396
AC:
44
AN:
1111426
Other (OTH)
AF:
0.00283
AC:
171
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
88
176
263
351
439
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0134
AC:
2042
AN:
152282
Hom.:
51
Cov.:
33
AF XY:
0.0129
AC XY:
959
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.0464
AC:
1926
AN:
41552
American (AMR)
AF:
0.00575
AC:
88
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68008
Other (OTH)
AF:
0.0114
AC:
24
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
100
199
299
398
498
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00492
Hom.:
29
Bravo
AF:
0.0155
ESP6500AA
AF:
0.0472
AC:
208
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00420
AC:
510
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.0000546
EpiControl
AF:
0.0000593

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
Congenital hyperammonemia, type I (3)
-
-
2
not provided (2)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.32
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Uncertain
0.060
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.94
D
Eigen
Uncertain
0.55
Eigen_PC
Uncertain
0.64
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.95
D
MetaRNN
Benign
0.0065
T
MetaSVM
Uncertain
0.26
D
MutationAssessor
Pathogenic
3.6
H
PhyloP100
6.1
PrimateAI
Uncertain
0.67
T
PROVEAN
Benign
-2.1
N
REVEL
Uncertain
0.64
Sift
Benign
0.034
D
Sift4G
Benign
0.10
T
Polyphen
0.37
B
Vest4
0.44
MVP
0.96
MPC
0.31
ClinPred
0.078
T
GERP RS
6.2
Varity_R
0.63
gMVP
0.88
Mutation Taster
=61/39
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs76340296; hg19: chr2-211513215; API